The EU Commission opens an investigation against two pharmaceutical companies on account of a patent settlement agreement (Cephalon / Teva)

KEYWORDS
Reference

EU Commission, Cephalon / Teva, Case No COMP/M.6258, 28 April 2011

On 28 April 2011, the European Commission opened of its own motion formal competition proceedings against Cephalon, Inc. (“Cephalon”) and Teva Pharmaceutical

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Author

  • Van Bael & Bellis (Brussels)
    Belgium 141 contributions 49095 visits

Quotation

Peter L'Ecluse, The EU Commission opens an investigation against two pharmaceutical companies on account of a patent settlement agreement (Cephalon / Teva), 28 April 2011, e-Competitions Pay-for-delay agreements, Art. N° 41138

Visites 454

All issues

  • Latest News issue 
  • All News issues
  • Latest Special issue 
  • All Special issues